Evidence map›Paper›PMID 23797672›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

The role of JAK-3 in regulating TLR-mediated inflammatory cytokine production in innate immune cells.

Huizhi Wang, Jonathan Brown, Shegan Gao, Shuang Liang, Ravi Jotwani, Huaxin Zhou, Jill Suttles, David A Scott, Richard J Lamont

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. A novel small molecule KMU-11361 attenuates rheumatoid arthritis by mechanistic inhibition of the TAK1-NF-κB-NLRP3 axis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Disease Risk-Associated Genetic Variants inJournal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Huizhi WangOral Health and Systemic Disease Research Group, University of Louisville School of Dentistry, Louisville, KY 40202, USA. hhwang01@louisville.edu
Jonathan Brown
Shegan Gao
Shuang Liang
Ravi Jotwani
Huaxin Zhou
Jill Suttles
David A Scott
Richard J Lamont
University of Louisville · USFirst Affiliated Hospital of Henan University of Science and Technology · CN

Funding

Role of GSK3 in host inflammationR01DE017680 · NIDCR · UNIVERSITY OF LOUISVILLE · PI SCOTT, DAVID A · 2007 to 2017
$3.3M
Role of JAKs in innate responses to P. gingivalisR01DE017921 · NIDCR · UNIVERSITY OF LOUISVILLE · PI LAMONT, RICHARD J · 2010 to 2019
$3.3M
Tobacco-induced alterations to P. gingivalis-host interactionsR01DE019826 · NIDCR · UNIVERSITY OF LOUISVILLE · PI SCOTT, DAVID A · 2010 to 2014
$1.8M
NIDCR NIH HHS R01 DE017680NIDCR NIH HHS R01 DE017921NIDCR NIH HHS R01 DE019826
6 · The paper itself

Abstract

The role of JAK-3 in TLR-mediated innate immune responses is poorly understood, although the suppressive function of JAK3 inhibition in adaptive immune response has been well studied. In this study, we found that JAK3 inhibition enhanced TLR-mediated immune responses by differentially regulating pro- and anti- inflammatory cytokine production in innate immune cells. Specifically, JAK3 inhibition by pharmacological inhibitors or specific small interfering RNA or JAK3 gene knockout resulted in an increase in TLR-mediated production of proinflammatory cytokines while concurrently decreasing the production of IL-10. Inhibition of JAK3 suppressed phosphorylation of PI3K downstream effectors including Akt, mammalian target of rapamycin complex 1, glycogen synthase kinase 3β (GSK3β), and CREB. Constitutive activation of Akt or inhibition of GSK3β abrogated the capability of JAK3 inhibition to enhance proinflammatory cytokines and suppress IL-10 production. In contrast, inhibition of PI3K enhanced this regulatory ability of JAK3 in LPS-stimulated monocytes. At the transcriptional level, JAK3 knockout lead to the increased phosphorylation of STATs that could be attenuated by neutralization of de novo inflammatory cytokines. JAK3 inhibition exhibited a GSK3 activity-dependent ability to enhance phosphorylation levels and DNA binding of NF-κB p65. Moreover, JAK3 inhibition correlated with an increased CD4(+) T cell response. Additionally, higher neutrophil infiltration, IL-17 expression, and intestinal epithelium erosion were observed in JAK3 knockout mice. These findings demonstrate the negative regulatory function of JAK3 and elucidate the signaling pathway by which JAK3 differentially regulates TLR-mediated inflammatory cytokine production in innate immune cells.

Indexed as

AnimalsCD4-Positive T-LymphocytesCells, CulturedCREB-Binding ProteinDNA-Binding ProteinsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHumansImmunity, InnateInflammationInterleukin-10Interleukin-17Intestinal MucosaIntestinesJanus Kinase 3LipopolysaccharidesCREB-Binding ProteinCrebbp protein, mouseDNA-Binding ProteinsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGSK3B protein, humanGsk3b protein, mouseInterleukin-10Interleukin-17Janus Kinase 3LipopolysaccharidesMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesNF-kappa BPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsProto-Oncogene Proteins c-aktRela protein, mouseRNA, Small InterferingToll-Like ReceptorsTOR Serine-Threonine KinasesTranscription Factor RelA

Identifiers

PMID23797672
PMCPMC3720823
OpenAlexW1957795404

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.